Use of WALANT in outpatient hand surgery and hand surgeons' knowledge of phentolamine as an antidote to WALANT solution for ischemic complications

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00033423

Enrollment

100

Registered

2024-01-15

Start date

2023-09-17

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knowledge WALANT/Phentolamin

Interventions

Group 1: The aim of this prospective study is to determine the use of WALANT by hand surgeons practicing in Germany with regard to the handling and procedure in the event of possible complications. Th

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All available Hand surgeons in Germany

Exclusion criteria

Exclusion criteria: No Hand or Plastic surgeons in Germany

Design outcomes

Primary

Measure	Time frame
By means of a questionnaire, we are pursuing the goal of recording the spread of the use of WALANT and the knowledge of hand surgeons in Germany about the available antidote phentolamine	—

Secondary

Measure	Time frame
See Primary outcome	—

Countries

Germany

Contacts

Public ContactAnieto Onochie Matthias Enechukwu

Medizinische Hochschule Hannover

Enechukwu.Anieto@mh-hannover.de0511173106

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026